The Pharmacological Profile of Cyclin-dependent Kinase (CDK) 4/6 Inhibitors: Clinical Management of Toxicity and Drug Interactions Related to CDK 4/6 Inhibitor-based Treatment in Advanced/Metastatic Breast Cancer

Catégorie d'article: Review Article

Publié en ligne: 05 avr. 2020

Pages: 2 - 14

Reçu: 12 mai 2019

Accepté: 07 oct. 2019

DOI: https://doi.org/10.2478/fco-2019-0007

Mots clés

Breast cancer, CDK4/6 inhibitors, toxicity, drug interactions, clinical management

© 2019 Tzelepi C. Vasiliki et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.